A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      FDA-regulated ProductStudies a U.S. FDA-Regulated Drug Product: YesStudies a U.S. FDA-Regulated Device Product: NoPlan to Share DataNoPlan to Share Data (IPD) DescriptionBMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Keywords: Abatacept Therapy; Actinomycetales Infections; Antirheumatics; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Gram-Positive Bacteria; Health and Medicine; Immunosuppressants; Mycobacterium Infections; Mycobacterium Infections - Tuberculosis; Mycobacterium Tuberculosis; Pharmaceuticals; Risk and Prevention; Tuberculosis EN Abatacept Therapy Actinomycetales Infections Antirheumatics Clinical Research Clinical Trials and Studies Drugs and Therapies Gram-Positive Bacteria Health and Medicine Immunosuppressants Mycobacterium Infections Mycobacterium Infections - Tuberculosis Mycobacterium Tuberculosis Pharmaceuticals Risk and Prevention Tuberculosis 302 302 1 08/21/23 20230824 NES 230824 2023 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Staff editors report on the newly launched clinical trial, NCT05981976, which has the following summary description: "The purpose of this study is to compare the relative absorption of abatacept in healthy participants following subcutaneous (SC) administration in which the drug substance is manufactured with the current or new process.". [Extracted from the article]
    • Abstract:
      Copyright of TB & Outbreaks Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)